id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-P-4027-0005,FDA,FDA-2017-P-4027,Relisting Notice Meticorten,Other,Background Material,2017-12-06T05:00:00Z,2017,12,2017-12-06T05:00:00Z,,2017-12-06T12:43:16Z,,0,0,0900006482ce317c
FDA-2017-P-4027-0004,FDA,FDA-2017-P-4027,"Determination That METICORTEN (Prednisone) Tablets, 1 Milligram and 5
Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or
Effectiveness",Notice,Determinations,2017-12-01T05:00:00Z,2017,12,2017-12-01T05:00:00Z,,2017-12-04T14:55:48Z,2017-25900,0,0,0900006482cc9ac1
FDA-2017-P-4027-0003,FDA,FDA-2017-P-4027,Attachment 1 Annex I - Orange book details - Prednisone Tablets 1 mg,Supporting & Related Material,Background Material,2017-07-03T04:00:00Z,2017,7,,,2017-07-03T16:06:54Z,,0,0,09000064827ded10
FDA-2017-P-4027-0002,FDA,FDA-2017-P-4027,Acknowledgment Letter from FDA DDM  to Strides Pharma Inc.,Other,Acknowledgement Letter/Receipt,2017-07-03T04:00:00Z,2017,7,2017-07-03T04:00:00Z,,2017-07-03T16:06:35Z,,0,0,09000064827ded0d
FDA-2017-P-4027-0001,FDA,FDA-2017-P-4027,Citizen Petition from Strides Pharma Inc,Other,Citizen Petition,2017-07-03T04:00:00Z,2017,7,2017-07-03T04:00:00Z,2018-01-02T04:59:59Z,2017-07-03T16:06:15Z,,0,0,09000064827de997